NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹56 Cr | ₹25 Cr | ₹0.75 Cr | ₹2.07 Cr | ₹3.44 Cr |
What is the latest Secured Loans ratio of NGL FINECHEM ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹56 Cr |
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹0.75 Cr |
| Mar2023 | ₹2.07 Cr |
| Mar2022 | ₹3.44 Cr |
How is Secured Loans of NGL FINECHEM Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹56 Cr | 122.62 | |
| Mar2025 | ₹25 Cr | 3,300.81 | |
| Mar2024 | ₹0.75 Cr | -64.06 | |
| Mar2023 | ₹2.07 Cr | -39.67 | |
| Mar2022 | ₹3.44 Cr | - | |
Compare Secured Loans of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,692.9 Cr | 6.6% | -10.4% | 92.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 6.6% |
-10.4% |
92.7% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses